| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |